Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13437 | 836 | 23.2 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
462 | 3 | HERNIA//INGUINAL HERNIA//INCISIONAL HERNIA | 24437 |
2814 | 2 | FIBRIN SEALANT//SEROMA//ANKAFERD BLOOD STOPPER | 3053 |
13437 | 1 | ANKAFERD BLOOD STOPPER//ANKAFERD//BONE WAX | 836 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANKAFERD BLOOD STOPPER | authKW | 1073784 | 5% | 70% | 42 |
2 | ANKAFERD | authKW | 832056 | 3% | 84% | 27 |
3 | BONE WAX | authKW | 649398 | 3% | 66% | 27 |
4 | FACTOR V INHIBITOR | authKW | 561900 | 2% | 77% | 20 |
5 | OXIDIZED CELLULOSE | authKW | 502338 | 3% | 49% | 28 |
6 | BOVINE THROMBIN | authKW | 488080 | 3% | 64% | 21 |
7 | ACQUIRED FACTOR V INHIBITOR | authKW | 365241 | 1% | 100% | 10 |
8 | SURGICEL | authKW | 301603 | 2% | 52% | 16 |
9 | TOPICAL HEMOSTATIC AGENTS | authKW | 298269 | 2% | 58% | 14 |
10 | ANKAFERD BLOOD STOPPER R | authKW | 255669 | 1% | 100% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Surgery | 2191 | 28% | 0% | 238 |
2 | Hematology | 1798 | 15% | 0% | 123 |
3 | Materials Science, Biomaterials | 571 | 5% | 0% | 38 |
4 | Peripheral Vascular Diseases | 322 | 6% | 0% | 54 |
5 | Engineering, Biomedical | 254 | 5% | 0% | 41 |
6 | Dentistry, Oral Surgery & Medicine | 242 | 5% | 0% | 40 |
7 | Clinical Neurology | 233 | 9% | 0% | 73 |
8 | Respiratory System | 160 | 4% | 0% | 35 |
9 | Cardiac & Cardiovascular System | 146 | 6% | 0% | 54 |
10 | Medicine, General & Internal | 89 | 6% | 0% | 54 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IGMP | 69195 | 1% | 32% | 6 |
2 | USC CARDIOVASC THORAC | 48697 | 0% | 67% | 2 |
3 | ANESTHESIOL GEN INTENS MED | 36524 | 0% | 100% | 1 |
4 | ARTHUR BLOOM HAEMPHILIA | 36524 | 0% | 100% | 1 |
5 | BIOMED ENGN FB 40 | 36524 | 0% | 100% | 1 |
6 | BIOMED TECHNOL WING POJ PURE | 36524 | 0% | 100% | 1 |
7 | CHANG GUNG MEM HOSP HEMA ONCOL | 36524 | 0% | 100% | 1 |
8 | COCUK CERRAHISI BILIM DALI | 36524 | 0% | 100% | 1 |
9 | DEPAT HISTOL EMBRYOL | 36524 | 0% | 100% | 1 |
10 | ELLIS FI EL CANC MED | 36524 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI | 17362 | 2% | 4% | 13 |
2 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 7233 | 2% | 1% | 18 |
3 | TURKISH JOURNAL OF HEMATOLOGY | 4552 | 1% | 2% | 7 |
4 | BLOOD COAGULATION & FIBRINOLYSIS | 3579 | 2% | 1% | 18 |
5 | JOURNAL OF INVESTIGATIVE SURGERY | 1984 | 1% | 1% | 7 |
6 | TURKISH JOURNAL OF MEDICAL SCIENCES | 1402 | 1% | 0% | 8 |
7 | BIOMATERIALS MEDICAL DEVICES AND ARTIFICIAL ORGANS | 1374 | 0% | 2% | 2 |
8 | AMERICAN JOURNAL OF HEMATOLOGY | 1183 | 2% | 0% | 14 |
9 | JOURNAL OF CARDIOTHORACIC SURGERY | 927 | 1% | 0% | 6 |
10 | JOURNAL OF BIOMEDICAL MATERIALS RESEARCH-APPLIED BIOMATERIALS | 674 | 0% | 2% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANKAFERD BLOOD STOPPER | 1073784 | 5% | 70% | 42 | Search ANKAFERD+BLOOD+STOPPER | Search ANKAFERD+BLOOD+STOPPER |
2 | ANKAFERD | 832056 | 3% | 84% | 27 | Search ANKAFERD | Search ANKAFERD |
3 | BONE WAX | 649398 | 3% | 66% | 27 | Search BONE+WAX | Search BONE+WAX |
4 | FACTOR V INHIBITOR | 561900 | 2% | 77% | 20 | Search FACTOR+V+INHIBITOR | Search FACTOR+V+INHIBITOR |
5 | OXIDIZED CELLULOSE | 502338 | 3% | 49% | 28 | Search OXIDIZED+CELLULOSE | Search OXIDIZED+CELLULOSE |
6 | BOVINE THROMBIN | 488080 | 3% | 64% | 21 | Search BOVINE+THROMBIN | Search BOVINE+THROMBIN |
7 | ACQUIRED FACTOR V INHIBITOR | 365241 | 1% | 100% | 10 | Search ACQUIRED+FACTOR+V+INHIBITOR | Search ACQUIRED+FACTOR+V+INHIBITOR |
8 | SURGICEL | 301603 | 2% | 52% | 16 | Search SURGICEL | Search SURGICEL |
9 | TOPICAL HEMOSTATIC AGENTS | 298269 | 2% | 58% | 14 | Search TOPICAL+HEMOSTATIC+AGENTS | Search TOPICAL+HEMOSTATIC+AGENTS |
10 | ANKAFERD BLOOD STOPPER R | 255669 | 1% | 100% | 7 | Search ANKAFERD+BLOOD+STOPPER+R | Search ANKAFERD+BLOOD+STOPPER+R |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BARKUN, AN , MOOSAVI, S , MARTEL, M , (2013) TOPICAL HEMOSTATIC AGENTS: A SYSTEMATIC REVIEW WITH PARTICULAR EMPHASIS ON ENDOSCOPIC APPLICATION IN GI BLEEDING.GASTROINTESTINAL ENDOSCOPY. VOL. 77. ISSUE 5. P. 692-700 | 57 | 80% | 26 |
2 | FRANCHINI, M , LIPPI, G , (2011) ACQUIRED FACTOR V INHIBITORS: A SYSTEMATIC REVIEW.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 31. ISSUE 4. P. 449-457 | 49 | 89% | 20 |
3 | STREIFF, MB , NESS, PM , (2002) ACQUIRED FV INHIBITORS: A NEEDLESS IATROGENIC COMPLICATION OF BOVINE THROMBIN EXPOSURE.TRANSFUSION. VOL. 42. ISSUE 1. P. 18-26 | 47 | 92% | 107 |
4 | HAZNEDAROGLU, BZ , BEYAZIT, Y , WALKER, SL , HAZNEDAROGLU, IC , (2012) PLEIOTROPIC CELLULAR, HEMOSTATIC, AND BIOLOGICAL ACTIONS OF ANKAFERD HEMOSTAT.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 83. ISSUE 1. P. 21 -34 | 37 | 93% | 13 |
5 | ANG, AL , KUPERAN, P , NG, CH , NG, HJ , (2009) ACQUIRED FACTORV INHIBITOR A PROBLEM-BASED SYSTEMATIC REVIEW.THROMBOSIS AND HAEMOSTASIS. VOL. 101. ISSUE 5. P. 852 -859 | 39 | 85% | 32 |
6 | KARAKOC, D , AKAR, E , AKSU, S , UNER, A , OZDEMIR, A , HAMALOGLU, E , OZENC, A , DOGRUL, A , MEMEDOVA, B , HAZNEDAROGLU, IC , (2012) HISTOPATHOLOGICAL ALTERATIONS IN THE KIDNEY TISSUE FOLLOWING TOPICAL ANKAFERD HEMOSTAT APPLICATION IN A RAT RENAL INJURY MODEL.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI. VOL. 22. ISSUE 4. P. 275-281 | 28 | 100% | 0 |
7 | KOLUMAN, A , AKAR, N , MALKAN, UY , HAZNEDAROGLU, IC , (2016) QUALITATIVE/CHEMICAL ANALYSES OF ANKAFERD HEMOSTAT AND ITS ANTIOXIDANT CONTENT IN SYNTHETIC GASTRIC FLUIDS.BIOMED RESEARCH INTERNATIONAL. VOL. . ISSUE . P. - | 35 | 69% | 0 |
8 | KNOBL, P , LECHNER, K , (1998) ACQUIRED FACTOR V INHIBITORS.BAILLIERES CLINICAL HAEMATOLOGY. VOL. 11. ISSUE 2. P. 305-318 | 36 | 97% | 65 |
9 | CLARK, J , CREAN, S , REYNOLDS, MW , (2008) TOPICAL BOVINE THROMBIN AND ADVERSE EVENTS: A REVIEW OF THE LITERATURE.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 24. ISSUE 7. P. 2071-2087 | 34 | 79% | 9 |
10 | OFOSU, FA , CREAN, S , REYNOLDS, MW , (2009) A SAFETY REVIEW OF TOPICAL BOVINE THROMBIN-INDUCED GENERATION OF ANTIBODIES TO BOVINE PROTEINS.CLINICAL THERAPEUTICS. VOL. 31. ISSUE 4. P. 679-691 | 40 | 63% | 17 |
Classes with closest relation at Level 1 |